Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is May 23, 2024.
All times in Eastern Daylight Time.
-
iStaging reveals Next Generation MR experiences at VivaTech 2024.TAIPEI, Taiwan--(BUSINESS WIRE)--iStaging is an innovative Mixed Reality SaaS company driven by computer vision & AI, backed by 10 years of technological development and 100,000 corporate users... more »
-
Mitsubishi Electric to Establish Vietnamese JV for FA ProductsTOKYO--(BUSINESS WIRE)--Mitsubishi Electric Corporation (TOKYO: 6503) announced today that it will acquire an 80% stake in Fuji Bakelite Vietnam Co., Ltd. in outskirts of Hanoi, a subsidiary of Fuj... more »
-
Mary Kay 玫琳凱在國際科學與工程大獎賽為五名有抱負的青年科學家頒發獎金達拉斯--(BUSINESS WIRE)--(美國商業資訊)-- Mary Kay (玫琳凱)是支持 STEM 教育並鼓勵年輕人追求夢想的企業,於近期由將近兩千名來自約 70 個國家的參賽者中選出五位傑出的高中青年科學家,並在洛杉磯的國際科學與工程大獎賽(International Science and Engineering Fair, 簡稱 ISEF)頒發了三筆獎金,總贈款額近 10,... more »
-
セルトリオン、欧州委員会からオマリズマブ バイオシミラー「Omlyclo®(CT-P39)」の承認を取得 – 欧州初・唯一の承認韓国・仁川--(BUSINESS WIRE)--(ビジネスワイヤ) -- (ビジネスワイヤ) -- セルトリオンは、欧州委員会(EC)がXolair®(オマリズマブ)のバイオシミラーであるOmlyclo®(CT-P39)を承認したことを発表しました。Omlyclo ®は、アレルギー性喘息、慢性特発性蕁麻疹(CSU)、鼻茸を伴う慢性副鼻腔炎(CRSwNP)の治療に適応されます。 欧州委員会(E... more »
-
Celltrion 賽特瑞恩獲歐盟執委會核准Omlyclo®(CT-P39),歐洲首個且唯一獲核准的omalizumab生物相似藥仁川,南韓--(BUSINESS WIRE)--(美國商業資訊)-- (美國商業資訊)-- Celltrion 賽特瑞恩今天宣布,歐盟執委會 (EC) 已核准Omlyclo ®(CT-P39),一款對照Xolair®的omalizumab生物相似藥® 。Omlyclo ®適用於治療過敏性氣喘、慢性自發性蕁麻疹 (CSU) 和慢性鼻竇炎合併鼻息肉 (CRSwNP) . 歐盟執委會核准Omlyc... more »
-
Celltrion riceve l'approvazione della Commissione europea per Omlyclo® (CT-P39), il primo e unico farmaco biosimilare di omalizumab approvato in EuropaINCHEON, Corea del Sud--(BUSINESS WIRE)--Celltrion ha annunciato oggi l'approvazione da parte della Commissione europea (CE) di Omlyclo® (CT-P39), un farmaco biosimilare di omalizumab con Xolair® c... more »
-
Celltrion krijgt goedkeuring van de Europese Commissie voor Omlyclo® (CT-P39), de eerste en biosimilar van omalizumab die in Europa is goedgekeurdINCHEON, Zuid-Korea--(BUSINESS WIRE)--Vandaag maakte Celltrion bekend dat de Europese Commissie (EC) het product Omlyclo® (CT-P39) heeft goedgekeurd, de eerste biosimilar van omalizumab van het ref... more »
-
Celltrion recibe la aprobación de la Comisión Europea para Omlyclo® (CT-P39), el primer y único biosimilar de omalizumab aprobado en EuropaINCHEON, Corea del Sur--(BUSINESS WIRE)--Celltrion ha anunciado hoy que la Comisión Europea (CE) ha aprobado Omlyclo® (CT-P39), un biosimilar de omalizumab que hace referencia a Xolair®. Omlyclo® e... more »
-
ZHEJIANG, Zhoushan--(BUSINESS WIRE)--On May 17, in Zhoushan, Zhejiang Province, the world's first five-terminal flexible DC transmission project, Zhoushan five-terminal VSC-HVDC transmission projec... more »
-
Celltrion receives European Commission approval of Omlyclo® (CT-P39), the first and only omalizumab biosimilar approved in EuropeINCHEON, South Korea--(BUSINESS WIRE)--Celltrion today announced that the European Commission (EC) has approved Omlyclo® (CT-P39), an omalizumab biosimilar referencing Xolair®. Omlyclo® is approved... more »
-
CMBM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cambium Networks Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Camb... more »
-
The 2024 ESSENCE Festival of Culture™ Celebrates 30 Years of Loving Us with Evening Performances from USHER for a Special One-Night Only 20th Anniversary of Confessions Milestone Moment, Janet Jackson, Charlie Wilson, Victoria Monét...NEW ORLEANS--(BUSINESS WIRE)-- The 2024 ESSENCE Festival of Culture™ Celebrates 30 Years of Loving Us with Evening Performances from USHER for a Special One-Night Only 20th Anniversary of Confessi... more »
-
Hagens Berman and Winston & Strawn Secure Historic Multibillion-Dollar Settlement for College Athletes and Bring Revolutionary Change to College SportsSAN FRANCISCO--(BUSINESS WIRE)--Hagens Berman and Winston & Strawn LLP with the NCAA and conferences reached a class-action settlement in ongoing name, image and likeness litigation. more »
-
Lee Leads Wire-to-Wire to Win MLF General Tire Heavy Hitters 2024 Presented by Bass Pro Shops on the Kissimmee Chain of LakesKISSIMMEE, Fla.--(BUSINESS WIRE)--The first time Abu Garcia pro Jordan Lee of Cullman, Alabama, ever tasted tournament victory, competing on Lake Guntersville at age 17, he earned the win throwing ... more »
-
Samenvatting: Canva onthult het Enterprise tijdperk met de presentatie van krachtige nieuwe werkplekproducten op Canva CreateLOS ANGELES--(BUSINESS WIRE)--Tijdens het eerste internationale Canva Create-evenement in Los Angeles heeft Canva, 's werelds enige alles-in-één visuele communicatieplatform, haar focus op de onder... more »